Key facts
- Notable investors include IKP EDEN, Manipal-GOK Bioincubator, Srinidhi Gadde, Startup Karnataka, Sunil Diwakar — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Quantumzyme
- ·The full record, as it builds
Funding rounds
No funding rounds for Quantumzyme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quantumzyme
Operator of a biotransformation company focused on clean and green chemistry designed to enhance the functionality of proteins through optimized amino acid sequence prediction. The company's platform offers integrated computational chemistry and bioinformatics tools combined with proprietary algorithms, enabling biotech and pharmaceutical researchers to improve enzyme performance and accelerate protein design workflows.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2016
- Employees
- 12
- Website
- quantumzyme.com/
- Ownership
- Privately Held (backing)
Quantumzyme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quantumzyme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quantumzyme in its N-PORT filings yet. We sweep new filings monthly.